<code id='E4A50FE058'></code><style id='E4A50FE058'></style>
    • <acronym id='E4A50FE058'></acronym>
      <center id='E4A50FE058'><center id='E4A50FE058'><tfoot id='E4A50FE058'></tfoot></center><abbr id='E4A50FE058'><dir id='E4A50FE058'><tfoot id='E4A50FE058'></tfoot><noframes id='E4A50FE058'>

    • <optgroup id='E4A50FE058'><strike id='E4A50FE058'><sup id='E4A50FE058'></sup></strike><code id='E4A50FE058'></code></optgroup>
        1. <b id='E4A50FE058'><label id='E4A50FE058'><select id='E4A50FE058'><dt id='E4A50FE058'><span id='E4A50FE058'></span></dt></select></label></b><u id='E4A50FE058'></u>
          <i id='E4A50FE058'><strike id='E4A50FE058'><tt id='E4A50FE058'><pre id='E4A50FE058'></pre></tt></strike></i>

          Home / comprehensive / explore

          explore


          explore

          author:entertainment    Page View:4588
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In